Completed NA INTERVENTIONAL NCT00003302

MRI to Detect Breast Tumors in Women

Breast MRI Protocol

Sponsor: Abramson Cancer Center at Penn Medicine

Interventions biopsy magnetic resonance imaging mammography

Updated 9 times since 2017 Last updated: Sep 23, 2019 Started: May 31, 1998 Primary completion: Jun 30, 2000 Completion: Jun 30, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00003302, this NA trial focuses on Breast Cancer and remains completed. Sponsored by Abramson Cancer Center at Penn Medicine, it has been updated 9 times since 1998, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2023 — Jul 2024 [monthly]

Completed NA
Jan 2021 — May 2023 [monthly]

Completed NA

▶ Show 4 earlier versions

Oct 2019 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
Apr 2019 — Oct 2019 [monthly]

Unknown Status NA
Jun 2018 — Apr 2019 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

May 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)

Data source: Abramson Cancer Center at Penn Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Baltimore, United States , Bonn, Germany , Boston, United States , Buffalo, United States , Chapel Hill, United States , Charlottesville, United States , Dallas, United States , Denver, United States , Halle, Germany , Houston, United States and 5 more locations